New UK vaccine trial targets virus linked to MS

The UK’s Horizon trial will test a vaccine against the Epstein-Barr virus (EBV), linked to multiple sclerosis, aiming to train the immune system and explore a potential new treatment for MS.

Advertisements



Latest Academic Articles

The latest academic articles from a wide range of themes such as energy, environment, health, agriculture, social sciences and technology plus more.

Open Access eBooks

The latest open access and free to distribute eBooks from key industry stakeholders covering health, energy, environment, plus more.

Horizon Europe

COP Climate Change

Special Reports